A Novel Approach to Plantar Fasciitis in the Aging Population The NAPA trial
A Novel Approach to Plantar Fasciitis in the Aging Population The NAPA trial
批准号:
10689012
负责人:
IRENE S DAVIS
金额:
$52.68万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2025-05-31
关键词:
AdultAgeAgingAtrophicChronicCumulative Trauma DisordersDrug PrescriptionsElderlyEquilibriumExerciseExhibitsFoot PainGoalsIncidenceIndividualInterventionKnee OsteoarthritisLaboratoriesMeasuresMental DepressionMethodsMonitorMuscleMuscle WeaknessMuscular AtrophyOlder PopulationOrthotic DevicesOutcome AssessmentOutcome MeasurePainParticipantPatientsPhysical FunctionPlantar FasciitisPlantar fascia structurePopulationQuality of lifeQuestionnairesRandomizedRecurrenceResearchResolutionRiskRisk ReductionShoesSiteStretchingSymptomsTestingTimeTrainingWalkingaging populationcomparison interventiondesignexperienceflexibilityfollow-upfootfunctional outcomesimprovedimproved outcomemuscle strengthnovelnovel strategiesprogramsrecruitresiliencestandard of careultrasoundwalking speed
中文摘要
足底筋膜炎是一种反复拉伤,是导致足部疼痛的最常见原因之一。10%的老龄化
成人会出现足底筋膜炎,50%的病例是残废的。足部疼痛可能会导致其他问题
例如行动不便、抑郁和处方药的使用,导致生活质量下降。
足部疼痛和虚弱、静态和动态平衡降低之间的关系已经确定,
老年人的行走速度也会减慢。足底筋膜炎的标准护理方法是用
足部矫形器和支撑鞋。然而,对牙弓的慢性支持已被证明会导致固有的
足部肌肉萎缩。由于足底筋膜炎与这种萎缩有关,因此采用慢性足弓支撑治疗。
只会增加复发的风险。事实上,有50%的复发率和45.6%的风险
足底筋膜炎在10年后出现症状的老年人。
最小的鞋子被设计成让脚自然地发挥作用,就像赤脚一样。他们已经是
成功地在老年人中实施,用于治疗膝骨性关节炎。最小的鞋子是高度
灵活,缺乏传统鞋类的支持。这对足部肌肉提出了更大的需求,
促进发展壮大。更强壮的足部固有肌肉已被证明可以减少足部肌肉的紧张。
足底筋膜的每一步,从而降低了发生足底筋膜炎的风险。
长期目标:改进老年成人足底筋膜炎的治疗干预措施。
具体目标:1.比较最小鞋(MF)和足底矫形器的疼痛和身体功能
(FO)组在3个月和6个月随访时,2.比较足部固有肌肉大小和力量的变化
比较MF组和FO组在3个月和6个月的随访期和3个月的复发率。
足底筋膜疼痛在12个月随访期的比较
方法:120例足底筋膜炎患者。将从2个地点招聘。他们将会是
随机分为最小鞋类(MF)组和足部矫形器(FO)组。足部肌肉大小的基线测量
力量,静态和动态平衡,6分钟。步行测试和两份功能结果问卷将
获得。MF组将得到2双最小的鞋子,FO组将得到2双支持
鞋子和预制的足部矫形器。MF组将接受为期4周的足部强化计划
和柔韧性练习,而FO组只接受柔韧性练习。两组都将被给予
一项为期8周的鞋类过渡计划,基于他们各自的基线步数。他们将返回到
实验室在3个月和6个月重复基线测量。足底筋膜痛和每日步数
在这一年中一直受到监测。预后指标与足底筋膜炎的比较
复发率将在两组之间进行比较。
英文摘要
Plantar fasciitis, a repetitive strain injury, is one of the most common causes of foot pain. Ten percent of aging
adults experience plantar fasciitis with 50% of the cases being disabling. Foot pain can lead to other problems
such as reduced mobility, depression and prescription medication use, leading to a reduced quality of life.
Relationships have been established between foot pain and weakness, reduced static and dynamic balance,
and reduced walking speed in aging adults. The standard of care for plantar fasciitis is to brace the foot with
foot orthoses and supportive shoes. However, chronic support of the arch has been shown to lead to intrinsic
foot muscle atrophy. As plantar fasciitis is associated with this atrophy, treating it with chronic arch support
only increases the risk for recurrence. In fact, there is a 50% recurrence rate and a 45.6% risk of having
plantar fasciitis 10 years after the onset of symptoms in older adults.
Minimal shoes are designed to allow the foot to function naturally, as if barefoot. They have already been
successfully implemented in older adults for the treatment of knee osteoarthritis. Minimal shoes are highly
flexible and lack the support of conventional footwear. This places greater demand on the foot muscles which
promotes strengthening. Stronger foot intrinsic foot muscles have been shown to reduce the strain on the
plantar fascia with each step, thereby reducing the risk of developing plantar fasciitis.
Long-term Goal: To improve treatment interventions for plantar fasciitis in aging adults.
Specific Aims: 1. Compare pain and physical function between the minimal footwear (MF) and the foot orthotic
(FO) groups at the 3 and 6 month follow-up, 2. Compare changes in intrinsic foot muscle size and strength
between MF and FO groups at the 3 and 6 month follow-up, and 3. Compare the incidence of recurrence of
plantar fascial pain between the MF and FO groups at the 12 month follow-up
Methods: 120 participants with plantar fasciitis (>6 mos.) will be recruited from 2 sites. They will be
randomized into a minimal footwear (MF) and foot orthotic (FO) group. Baseline measures of foot muscle size
and strength, static and dynamic balance, 6 min. walk test and two functional outcome questionnaires will be
obtained. The MF group will receive 2 pair of minimal shoes, and the FO group will receive 2 pair of supportive
shoes and prefabricated foot orthoses. The MF group will be given a 4-week program of foot strengthening
and flexibility exercises, while the FO group will only receive the flexibility exercises. Both groups will be given
an 8-week footwear transition program based upon their individual baseline step counts. They will return to the
laboratory to repeat the baseline measures at 3 and 6 mos. Plantar fascial pain and daily step counts will be
monitored over the course of the year. Comparisons in outcome measures as well as plantar fasciitis
recurrence will be compared between the groups.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Approach to Plantar Fasciitis in the Aging Population The NAPA trial
-
批准号:10367293
-
项目类别:
-
资助金额:$77.31万
-
财政年份:2022
-
负责人:IRENE S DAVIS
-
依托单位:
NIH-BIOMECHANICS IN MOVEMENT SCIENCE: BUILDING TRANSDOMAIN BRIDGES
-
批准号:7805092
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2010
-
负责人:IRENE S DAVIS
-
依托单位:
Real-time Gait Retraining to Reduce Loading in Runners
-
批准号:7262652
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2007
-
负责人:IRENE S DAVIS
-
依托单位:
Real-time Gait Retraining to Reduce Loading in Runners
-
批准号:7429765
-
项目类别:
-
资助金额:$28.58万
-
财政年份:2007
-
负责人:IRENE S DAVIS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: